- Home
- PTGX vs BGC Comparison
PTGX vs BGC Comparison
Compare PTGX & BGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PTGX | BGC |
|---|---|---|
| Founded | 2006 | 1945 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.4B |
| IPO Year | 2016 | 1999 |
Fundamental Metrics
Financial Performance| Metric | PTGX | BGC |
|---|---|---|
| Price | $98.97 | $9.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 2 |
| Target Price | ★ $106.67 | $14.50 |
| AVG Volume (30 Days) | 811.3K | ★ 2.1M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.85% |
| EPS Growth | N/A | ★ 24.00 |
| EPS | N/A | ★ 0.31 |
| Revenue | N/A | ★ $2,941,460,000.00 |
| Revenue This Year | $867.86 | $20.41 |
| Revenue Next Year | N/A | $8.40 |
| P/E Ratio | ★ N/A | $30.53 |
| Revenue Growth | N/A | ★ 29.99 |
| 52 Week Low | $39.60 | $7.24 |
| 52 Week High | $105.69 | $10.96 |
Technical Indicators
Market Signals| Indicator | PTGX | BGC |
|---|---|---|
| Relative Strength Index (RSI) | 56.73 | 48.47 |
| Support Level | $76.63 | $9.10 |
| Resistance Level | $100.00 | $9.85 |
| Average True Range (ATR) | 4.71 | 0.29 |
| MACD | 0.12 | -0.03 |
| Stochastic Oscillator | 53.74 | 46.00 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About BGC BGC Group Inc.
BGC Group Inc is a brokerage and financial technology company that serves financial markets, energy, and commodities markets. Its service and product offerings include brokerage for a wide range of financial products, including fixed income, equities, commodities, derivatives, and real estate, software solutions for trading platforms, clearing, trade execution, and other back-office services. Its clients mostly include banks, financial institutions, and corporate clients. BGC operates in one reportable segment, which is providing brokerage services. Geographically, the company generates a majority of its revenue from Europe, Middle East and Africa (EMEA), followed by the Americas and the Asia-Pacific region.